White Guide and Orange Guide Formatting Project - Pfizer

More documents

Recommendations

Info

Orange Guide – Chapter 17: State Laws: HCP and State Employee Restrictions State Important Provisions of the State Law Key Points to Ensure Compliance Nevada Nevada Marketing Code of Conduct requires companies to adopt a marketing code of conduct – the PhRMA Code is acceptable. 254 No specific guidance, other than to follow all Pfizer policies and procedures. Rev. 09/12 Page 8 of 38
Orange Guide – Chapter 17: State Laws: HCP and State Employee Restrictions State Important Provisions of the State Law Key Points to Ensure Compliance Vermont Vermont prohibits all HCP meals, including in-office meals and meals of nominal value (there is a limited exception for: (i) bona fide service contracts and (ii) refreshments or other snacks at a booth at a convention/congress). Vermont also prohibits paid market research surveys involving VT licensed HCPs. The restriction applies whether the survey is conducted directly by Pfizer or through an independent third party survey research organization. Pfizer must report certain HCP expenditures, as well as samples, coupons and vouchers, to VT. Price Disclosure Forms must be provided to HCPs when detailing and posted on Pfizer’s website. 255 Do not invite VT HCPs to any speaker programs that provide meals or snacks (even if the program is conducted outside of VT). Do not provide VT HCPs with meals or snacks (except refreshments or snacks in a convention setting). Do not engage VT HCPs as part of any paid marketing research surveys. Accurately and completely record all HCP expenditures, as well as samples, coupons and vouchers provided to VT licensed HCPs. If you are unsure of whether an HCP has a VT license, you can check the HCP License List which is available on the “State Healthcare Law Compliance” tab on http://OpSource.Pfizer.com or under the Compliance tab on PfieldNet. Also, iCUE flags most (but not all) VT HCPs. You must make a good faith effort to determine whether an HCP is licensed in VT. Provide VT Price Disclosure Forms to HCPs as appropriate (available on PfieldNet). Rev. 09/12 Page 9 of 38
Page 1 and 2:
Dear Colleagues: Pfizer Inc 235 Eas
Page 3 and 4:
To expand the bookmarks for a chapt
Page 5 and 6:
Orange Guide - Chapter 1: Overview
Page 7 and 8:
Page 9 and 10:
Page 11 and 12:
Page 13 and 14:
Page 15 and 16:
Foreign Corrupt Practices Act Orang
Page 17 and 18:
Pfizer’s Corporate Integrity Agre
Page 19 and 20:
Page 21 and 22:
Orange Guide - Chapter 2: Detailing
Page 23 and 24:
Key Points to Ensure Compliance Ora
Page 25 and 26:
Page 27 and 28:
Communicating Formulary Status Mail
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
Hospital Protocols Comparative Clai
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
Interacting with RMRS Colleagues Or
Page 41 and 42:
Page 43 and 44:
Page 45 and 46:
Page 47 and 48:
Detailing at Journal Club Meetings
Page 49 and 50:
Orange Guide - Chapter 3: Support o
Page 51 and 52:
Page 53 and 54:
Page 55 and 56:
Medical Education Grants Overview O
Page 57 and 58:
International Grant Activity Orange
Page 59 and 60:
Page 61 and 62:
“Not-for-Profit” Defined Orange
Page 63 and 64:
Page 65 and 66:
Page 67 and 68:
Information on Pfizer’s External
Page 69 and 70:
Overview Orange Guide - Chapter 3:
Page 71 and 72:
Awards, Scholarships and Fellowship
Page 73 and 74:
Page 75 and 76:
Orange Guide - Chapter 4: Federal E
Page 77 and 78:
Page 79 and 80:
Page 81 and 82:
Promotional Activities Orange Guide
Page 83 and 84:
Page 85 and 86:
Speaker Program Meals Part-Time VA
Page 87 and 88:
Page 89 and 90:
Page 91 and 92:
Page 93 and 94:
Page 95 and 96:
Page 97 and 98:
Page 99 and 100:
Page 101 and 102:
Orange Guide - Chapter 5: Interacti
Page 103 and 104:
Page 105 and 106:
Page 107 and 108:
Page 109 and 110:
Page 111 and 112:
Page 113 and 114:
Page 115 and 116:
Discussing Payer Rebates Medical Ac
Page 117 and 118:
Page 119 and 120:
Orange Guide - Chapter 6: Clinical
Page 121 and 122:
Page 123 and 124:
Page 125 and 126:
Page 127 and 128:
Orange Guide - Chapter 7: P&T Commi
Page 129 and 130:
Page 131 and 132:
Questions From a P&T Committee Memb
Page 133 and 134:
Page 135 and 136:
Page 137 and 138:
Page 139 and 140:
Orange Guide - Chapter 8: Privacy:
Page 141 and 142:
Page 143 and 144:
Page 145 and 146:
Seek Only De-Identified Data Orange
Page 147 and 148:
Consent Forms and Mentorships Orang
Page 149 and 150:
REMEMBER Orange Guide - Chapter 8:
Page 151 and 152:
Proper Use of HCP Prescriber Data O
Page 153 and 154:
Page 155 and 156:
Page 157 and 158:
Orange Guide - Chapter 9: Speaker P
Page 159 and 160:
Page 161 and 162:
Speaker Selection Scheduling Issues
Page 163 and 164:
Use of Pfizer Approved Speaker Slid
Page 165 and 166:
Page 167 and 168:
Page 169 and 170:
Providing In-Office Meals to Office
Page 171 and 172:
U.S. HCP Payment Disclosure Policy
Page 173 and 174:
Page 175 and 176:
Closeouts Orange Guide - Chapter 9:
Page 177 and 178:
Page 179 and 180:
Physical Separation of Speaker Prog
Page 181 and 182:
Chapter 10: STARTERS CONTENTS Start
Page 183 and 184:
Key Points to Ensure Compliance Ora
Page 185 and 186:
Orange Guide - Chapter 10: Starters
Page 187 and 188:
Inclusion of Materials with Starter
Page 189 and 190:
Page 191 and 192:
Distribution of Starters to Colleag
Page 193 and 194:
Page 195 and 196:
Page 197 and 198:
Page 199 and 200:
Orange Guide - Chapter 11: Patient
Page 201 and 202:
Page 203 and 204:
Page 205 and 206:
A special note about Medicare Part
Page 207 and 208: Refer any questions to your team at
Page 209 and 210: Chapter 12: CONTRACTING Introductio
Page 211 and 212: Orange Guide - Chapter 12: Contract
Page 213 and 214: Orange Guide - Chapter 12: Contract
Page 215 and 216: Key Points to Ensure Compliance Ora
Page 217 and 218: Chapter 13: HEALTH SCREENINGS Intro
Page 219 and 220: Orange Guide - Chapter 13: Health S
Page 221 and 222: If organized by Pfizer: Orange Guid
Page 223 and 224: Orange Guide - Chapter 13: Health S
Page 225 and 226: Orange Guide - Chapter 14: CGC Tool
Page 227 and 228: Orange Guide - Chapter 14: CGC Tool
Page 229 and 230: Discussing Pfizer Products While Me
Page 231 and 232: Orange Guide - Chapter 15: Non-Reba
Page 237 and 238: Orange Guide - Chapter 16: Consumer
Page 243 and 244: Providing Food to Consumers at a Di
Page 247 and 248: Content of Consumer Slide Decks Att
Page 249 and 250: Adverse Events Orange Guide - Chapt
Page 251 and 252: Orange Guide - Chapter 17: State La
Page 257: Orange Guide - Chapter 17: State La
Page 263 and 264: California Orange Guide - Chapter 1
Page 277 and 278: Educational Items Orange Guide - Ch
Page 289 and 290: Orange Guide - Chapter 18: Meals, E
Page 293 and 294: Meals to HCPs Orange Guide - Chapte
Page 309 and 310:
Orange Guide - Chapter 18: Meals, E
Page 311 and 312:
Orange Guide - Chapter 19: Sales Ac
Page 313 and 314:
Pricing Considerations Orange Guide
Page 315 and 316:
Page 317 and 318:
Page 319 and 320:
Page 321:
show all

White Guide and Orange Guide Formatting Project - Pfizer

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?